Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico

• Main Authors: Matthew Wasserman (Author), Maria Gabriela Palacios (Author), Ana Gabriela Grajales (Author), F. Berenice Baez/Revueltas (Author), Michele Wilson (Author), Cheryl McDade (Author), Raymond Farkouh (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccines (PCV13) since their inclusion in the National Immunization Program (...